Charlie Hospital Semarang Tbk. vs Sinarmas Multiartha Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Sinarmas Multiartha Tbk. trades at Rp20,600 (market cap 131.17T). The key difference: Sinarmas Multiartha Tbk. is far larger — about 176.8× Charlie Hospital Semarang Tbk.'s market cap. Which is the better fit depends on your goals.
| RSCH | SMMA | |
|---|---|---|
Market Cap | 742B | 131.17T |
Volume | 29.45M | — |
Lot | 294.49K | — |
Turnover | 8.14B | — |
Average Price | 276.35 | — |
Value | 8.14B | — |
Indicative Equilibrium Price | 270 | — |
Indicative Equilibrium Volume | 103 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Sinar Mas Multiartha Tbk was established by Deed No. 60 dated October 21, 1982 from Benny Kristianto, S.H., notary in Jakarta. PT Sinar Mas Multiartha was initially active in commercial leasing, consumer financing and venture capital, and purely became a holding company in the Sinar Mas Group.
Read more on SMMA →